proqolid

Home > Instruments > UCLA Prostate Cancer Index Short Form (UCLA-PCI-SF)

INSTRUMENT DETAILS

UCLA Prostate Cancer Index Short Form (UCLA-PCI-SF)

 

Derived from the UCLA-PCI in 1999

Includes the RAND 12-Item Health Survey v2 (SF-12 v2)

 

Author(s)

Litwin Mark S, MD, MPH; Brook Robert H, MD, ScD; Fink Arlene, PhD; Ganz Patricia A, MD; Hays Ron D, PhD; Leake Barbara, PhD

 

Purpose

  • Pathology:

Male genital diseases

Neoplasms

  • Disease:

Genital neoplasms, Male

[ prostate neoplasms ]

  • Objective:

To assess the impact of treatment for early stage prostate cancer on quality of life

  • Population for intended use:

Adult

Male

 
 

Characteristics

  • Type of instrument:

Health-Related Quality of Life - HRQL (incl. health status)

  • Administration mode:

Self-administered

  • Number of items:

15

  • Recall/Observation period:

During the past four weeks

 
 

Language(s)

  • Original language:

English for the USA

  • List of existing translations:

The translations listed below may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.
This list of translations is subject to constant changes, therefore please check the status of translations with MAPI Research Trust / the developers / copyright holders / distributors.

UCLA-PCI-SF

French for France
Japanese for Japan
Spanish for Spain
 

Bibliographic reference(s) of the original questionnaire

Litwin MS, McGuigan KA. Accuracy of recall in health-related quality-of-life assessment among men treated for prostate cancer. J Clin Oncol. 1999 Sep;17(9):2882-8

Last update: April 2012

Last update in collaboration with the author: April 2008